# OnCo record ga68-edotreotide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ga68-edotreotide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ga68-edotreotide" ;
  schema:name "Gallium-68 edotreotide (DOTATOC)"@en ;
  schema:alternateName "edotreotide"@en, "SomaKit TOC"@en, "68Ga-edotreotide"@en, "Ga-68 DOTATOC"@en, "gallium (68Ga) edotreotide"@en, "SomaKit TOC" ;
  schema:description "SomaKit TOC is a kit used to make a radioactive tracer for a PET scan in adults known or thought to have a neuroendocrine tumour of the gut or pancreas. The tracer sticks to the tumour cells so the scan can show where the tumour started and where it has spread."@en ;
  schema:url <https://onco.cc/drugs/ga68-edotreotide/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/somakit-toc> ;
  onco:status "approved" ;
  onco:tag "universe-gap", "ema-register", "diagnostic" ;
  onco:modality "PET radiotracer kit (somatostatin receptor ligand, labelled with gallium-68)" ;
  onco:approval "EU 2016: PET imaging of somatostatin receptor overexpression in adults with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NET), to localise primary tumours and metastases" ;
  onco:related <https://onco.cc/drugs/ga68-dotatate/> ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:technologies <https://onco.cc/technologies/sstr-pet/>, <https://onco.cc/technologies/pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:companies <https://onco.cc/companies/novartis/> .